The Texas Department of State Health Services (DSHS) has released its 2013 annual report describing healthcare-associated infections (HAIs) in Texas healthcare facilities.
The report provides data reported for the following HAIs: central line-associated bloodstream infections (CLABSIs), catheter associated urinary tract infections (CAUTIs) and surgical site infections (SSIs) related to various surgical procedures. The report indicates Texas general hospitals and ambulatory surgery centers are showing improvement when compared to national data for CLABSIs and SSIs.
Visit Texas’ website for more information about HAI reporting in Texas and facility-specific HAI data reports.
Source: CDC
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.